Medical Dialogues

Diclofenac and Silymarin Gel May Prevent Chemotherapy-Induced Hand-Foot Syndrome: JAMA

Hand-foot syndrome is a painful side effect commonly seen with chemotherapy drugs like capecitabine. Evidence suggests that ...
ascopubs.org

Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Absence of Biallelic TCRγ Deletion Predicts Early Treatment Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia Chemotherapy-naive patients with GI tract cancers scheduled for ...
ascopubs.org

Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial

Hand-foot syndrome (HFS) is a dose-limiting side effect of capecitabine. Celecoxib prevents HFS by inhibiting cyclooxygenase-2 (COX-2) that is upregulated because of the underlying associated ...
BioWorld

Onquality receives IND clearance for OQL-036 for capecitabine-induced hand-foot syndrome

Onquality Pharmaceuticals LLC has received FDA clearance of its IND application for OQL-036, a potential prophylactic treatment for capecitabine-induced hand-foot syndrome (HFS).
Renal & Urology News

Hand-Foot Syndrome May Predict Better Sunitinib Outcomes

ORLANDO—Patients with metastatic renal cell carcincoma (RCC) who develop hand-foot syndrome (HFS) while being treated with sunitinib may have better progression-free survival and overall survival than ...
Oklahoma's News

OnQuality Announces FDA Clearance of IND Application for OQL036 for the Prophylaxis of Capecitabine-Induced Hand-Foot Syndrome

SEATTLE, April 28, 2023 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted oncology supportive therapy company developing innovative medications to address unmet needs in ...